Literature DB >> 6239958

The effect of sequential multiple grafting of syngeneic newborn thymus on the immune functions and life expectancy of aging mice.

K Hirokawa, M Utsuyama.   

Abstract

Enhancement of the immune functions and extension of the mean life expectancy were successfully performed in aging mice by sequential multiple grafting of syngeneic newborn thymus. In the first experiment, 2-month-old female C57BL/6 mice were grafted with either syngeneic newborn thymus or newborn spleen every 2 months, 5 or 6 times. A significant enhancement of T cell dependent immune functions were observed in the group sequentially grafted with newborn thymus, in comparison to that grafted with multiple sequential newborn spleen or with a single newborn thymus and that without a graft. In the second experiment, the same sequential grafting protocol was performed in middle aged mice at monthly interval for 4-5 consecutive months and the immune functions and survival rate were compared between the experimental and control groups. The immune functions were only partially rejuvenated, but an extension of the mean remaining life expectancy was observed in the experimental group (312 +/- 38 days) as compared with control (214 +/- 42 days), although maximal life-span was the same in both groups (1100 days).

Entities:  

Mesh:

Year:  1984        PMID: 6239958     DOI: 10.1016/0047-6374(84)90157-x

Source DB:  PubMed          Journal:  Mech Ageing Dev        ISSN: 0047-6374            Impact factor:   5.432


  3 in total

1.  Both age and gender affect thymic output: more recent thymic migrants in females than males as they age.

Authors:  J Pido-Lopez; N Imami; R Aspinall
Journal:  Clin Exp Immunol       Date:  2001-09       Impact factor: 4.330

Review 2.  Thymic hormones--a clinical update.

Authors:  M B Sztein; A L Goldstein
Journal:  Springer Semin Immunopathol       Date:  1986

3.  Novel approaches for immune reconstitution and adaptive immune modeling with human pluripotent stem cells.

Authors:  Michael D Green; Hans-Willem Snoeck
Journal:  BMC Med       Date:  2011-05-10       Impact factor: 8.775

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.